[1]	Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025[J]. CA Cancer J Clin, 2025, 75(1): 10-45. DOI: 10.3322/caac.21871. Cited in this article [1]

[2]	Spronk I, Schellevis FG, Burgers JS, et al. Incidence of isolated local breast cancer recurrence and contralateral breast cancer: A systematic review[J]. Breast, 2018, 39(6): 70-79. DOI: 10.1016/j.breast.2018.03.011. Cited in this article [1]

[3]	Cardoso F, Castiglione M, Group EGW. Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up[J]. Ann Oncol, 2009, 20(4): 15-18. DOI: 10.1093/annonc/mdp115. Cited in this article [1]

[4]	Dinh P, Cardoso F, Sotiriou C, et al. New tools for assessing breast cancer recurrence[J]. Cancer Treat Res, 2008, 141: 99-118. DOI: 10.1007/978-0-387-73161-2_7. Cited in this article [1]

[5]	中国抗癌协会乳腺癌专业委员会, 中华医学会肿瘤学分会乳腺肿瘤学组. 中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J]. 中国癌症杂志, 2023, 33 (12): 1092-1187. DOI: 10.19401/j.cnki.1007-3639.2023.12.004. Cited in this article [17]

[6]	Ma JF, Chen LY, Wu SL, et al. Clinical practice guidelines for ultrasound-guided breast lesions and lymph nodes biopsy: Chinese society of breast surgery (CSBrS) practice guidelines 2021[J]. Chin Med J (Engl), 2021, 134(12): 1393-1395. DOI: 10.1097/CM9.0000000000001549. Cited in this article [5]

[7]	Gradishar WJ, Moran MS, Abraham J, et al. Breast Cancer, Version 3.2024, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2024, 22(5): 331-357. DOI: 10.6004/jnccn.2024.0035. Cited in this article [18]

[8]	Yin W, Di G, Zhou L, et al. Time-varying pattern of recurrence risk for Chinese breast cancer patients[J]. Breast Cancer Res Treat, 2009, 114(3): 527-535. DOI: 10.1007/s10549-008-0022-5. Cited in this article [1]

[9]	Demicheli R, Abbattista A, Miceli R, et al. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy[J]. Breast Cancer Res Treat, 1996, 41(2): 177-185. DOI: 10.1007/BF01807163. Cited in this article [1]

[10]	Fowble B. Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer[J]. Acta Oncol, 1999, 38(13): 9-17. DOI: 10.1080/028418699432716. Cited in this article [1]

[11]

Sasson AR, Fowble B, Hanlon AL, et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation[J]. Cancer, 2001, 91(10): 1862-1869. DOI: 10.1002/1097-0142(20010515)91:10<1862::aid-cncr1207>3.0.co;2-#. Cited in this article [1]

[12]	Cardoso F, Paluch-Shimon S, Senkus E, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)[J]. Ann Oncol, 2020, 31(12):1623-1649. DOI: 10.1016/j.annonc.2020.09.010. Cited in this article [1]

[13]	Rong J, Wang S, Ding Q, et al. Comparison of 18FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis[J]. Surg Oncol, 2013, 22(2): 86-91. DOI: 10.1016/j.suronc.2013.01.002. Cited in this article [1]

[14]	Groheux D, Cochet A, Humbert O, et al. 18F-FDG PET/CT for staging and restaging of breast cancer[J]. J Nucl Med, 2016, 57(1): 17S-26S. DOI: 10.2967/jnumed.115.157859. Cited in this article [1]

[15]	Groheux D, Hindie E, Marty M, et al. 18F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer[J]. Eur J Radiol, 2014, 83(10): 1925-1933. DOI: 10.1016/j.ejrad.2014.05.037. Cited in this article [1]

[16]	Veit-Haibach P, Antoch G, Beyer T, et al. FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy[J]. Br J Radiol, 2007, 80(955): 508-515. DOI: 10.1259/bjr/17395663. Cited in this article [1]

[17]

Demicheli R, Ardoino I, Boracchi P, et al. Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast[J]. BMC Cancer, 2010, 10: 656-664. DOI: 10.1186/1471-2407-10-656. Cited in this article [1]

[18]	De Hert S, Staender S, Fritsch G, et al. Pre-operative evaluation of adults undergoing elective noncardiac surgery: Updated guideline from the European Society of Anaesthesiology[J]. Eur J Anaesthesiol, 2018, 35(6): 407-465. DOI: 10.1097/EJA.0000000000000817. Cited in this article [1]

[19]

Walstra C, Schipper RJ, van Riet YE, et al. Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands[J]. Breast Cancer Res Treat, 2021, 187(2): 499-514. DOI: 10.1007/s10549-021-06154-2. Cited in this article [1]

[20]	Walstra C, Schipper RJ, Poodt IGM, et al. Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: A systematic review[J]. Eur J Surg Oncol, 2019, 45(8): 1317-1327. DOI: 10.1016/j.ejso.2019.02.008. Cited in this article [1]

[21]

Arthur DW, Winter KA, Kuerer HM, et al. Effectiveness of breast-conserving surgery and 3-dimensional conformal partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: The NRG Oncology/RTOG 1014 phase 2 clinical trial[J]. JAMA Oncol, 2020, 6(1): 75-82. DOI: 10.1001/jamaoncol.2019.4320. Cited in this article [1]

[22]	ElSherif A, Shah C, Downs-Kelly E, et al. Outcomes of ipsilateral breast tumor recurrence after breast conserving surgery: Repeat lumpectomy as an alternative to salvage mastectomy[J]. Surgery, 2022, 171(3): 673-681. DOI: 10.1016/j.surg.2021.10.069. Cited in this article [1]

[23]

Alpert TE, Kuerer HM, Arthur DW, et al. Ipsilateral breast tumor recurrence after breast conservation therapy: Outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation[J]. Int J Radiat Oncol Biol Phys, 2005, 63(3): 845-851. DOI: 10.1016/j.ijrobp.2005.02.035. Cited in this article [1]

[24]	Headon HL, Kasem A, Mokbel K. The oncological safety of nipple-sparing mastectomy: A systematic review of the literature with a pooled analysis of 12,358 procedures[J]. Arch Plast Surg, 2016, 43(4):328-338. DOI: 10.5999/aps.2016.43.4.328. Cited in this article [1]

[25]	Hannoun-Levi JM, Houvenaeghel G, Ellis S, et al. Partial breast irradiation as second conservative treatment for local breast cancer recurrence[J]. Int J Radiat Oncol Biol Phys, 2004, 60(5): 1385-1392. DOI: 10.1016/j.ijrobp.2004.05.035. Cited in this article [1]

[26]	Halverson KJ, Perez CA, Kuske RR, et al. Locoregional recurrence of breast cancer: A retrospective comparison of irradiation alone versus irradiation and systemic therapy[J]. Am J Clin Oncol, 1992, 15(2): 93-101 Cited in this article [1]

[27]

Hannoun-Levi JM, Resch A, Gal J, et al. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: Multicentric study of the GEC-ESTRO Breast Cancer Working Group[J]. Radiother Oncol, 2013, 108(2): 226-231. DOI:10.1016/j.radonc.2013.03.026. Cited in this article [1]

[28]	Newman LA, Hunt KK, Buchholz T, et al. Presentation, management and outcome of axillary recurrence from breast cancer[J]. Am J Surg, 2000, 180(4): 252-256. DOI: 10.1016/s0002-9610(00)00456-6. Cited in this article [3]

[29]	de Boer R, Hillen HF, Roumen RM, et al. Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer[J]. Br J Surg, 2001, 88(1): 118-122. DOI: 10.1046/j.1365-2168.2001.01637.x. Cited in this article [2]

[30]	Bulte JP, van Wely BJ, Kasper S, et al. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: Effect on prognosis and survival[J]. Breast Cancer Res Treat, 2013, 140(1): 143-149. DOI: 10.1007/s10549-013-2608-9. Cited in this article [3]

[31]	Konkin DE, Tyldesley S, Kennecke H, et al. Management and outcomes of isolated axillary node recurrence in breast cancer[J]. Arch Surg, 2006, 141(9): 867-874. DOI: 10.1001/archsurg.141.9.867. Cited in this article [1]

[32]	Pedersen AN, Moller S, Steffensen KD, et al. Supraclavicular recurrence after early breast cancer: A curable condition?[J]. Breast Cancer Res Treat, 2011, 125(3): 815-822. DOI: 10.1007/s10549-010-0918-8. Cited in this article [3]

[33]	Chen SC, Chang HK, Lin YC, et al. Prognosis of breast cancer after supraclavicular lymph node metastasis: Not a distant metastasis[J]. Ann Surg Oncol, 2006, 13(11): 1457-1465. DOI: 10.1245/s10434-006-9012-1.

[34]

Brito RA, Valero V, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience[J]. J Clin Oncol, 2001, 19(3): 628-633. DOI: 10.1200/JCO.2001.19.3.628. Cited in this article [1]

[35]	Chu FC, Lin FJ, Kim JH, et al. Locally recurrent carcinoma of the breast. Results of radiation therapy[J]. Cancer, 1976, 37(6): 2677-2681. DOI: 10.1002/1097-0142(197606)37:6<2677::aid-cncr2820370616>3.0.co;2-l. Cited in this article [1]

[36]	Jackson SM. Carcinoma of the breast--the significance of supraclavicular lymph node metastases[J]. Clin Radiol, 1966, 17(2): 107-114. DOI: 10.1016/s0009-9260(66)80066-1. Cited in this article [1]

[37]	Willner J, Kiricuta I, Kolbl O, et al. Supraclavicular lymph-node recurrence of breast-cancer[J]. Oncol Rep, 1994, 1(6): 1235-1245. DOI: 10.3892/or.1.6.1235. Cited in this article [1]

[38]	Fentiman IS, Lavelle MA, Caplan D, et al. The significance of supraclavicular fossa node recurrence after radical mastectomy[J]. Cancer, 1986, 57(5): 908-910. DOI: 10.1002/1097-0142(19860301)57:5<908::aid-cncr2820570504>3.0.co;2-q. Cited in this article [1]

[39]

Tang P, Hu Y, Wang ZH, et al. Clinical practice guidelines for endoscopic breast surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021[J]. Chin Med J (Engl), 2021, 134(21): 2532-2534. DOI: 10.1097/CM9.0000000000001592. Cited in this article [1]

[40]	Gibbs NM. Venous thrombosis of the lower limbs with particular reference to bed-rest[J]. Br J Surg, 1957, 45(191): 209-236. DOI: 10.1002/bjs.18004519102. Cited in this article [1]